Effectiveness of Neridronate in the Management of Bone Loss in Patients with Duchenne Muscular Dystrophy: Results from a Pilot Study

INTRODUCTION: Bone loss is a major issue in patients affected by Duchenne muscular dystrophy (DMD), a rare musculoskeletal disorder, particularly in those treated with glucocorticoids (GCs). We aimed to assess the effectiveness of neridronate in terms of bone mineral density (BMD) changes in this po...

Descripción completa

Detalles Bibliográficos
Autores principales: Moretti, Antimo, Liguori, Sara, Paoletta, Marco, Gimigliano, Francesca, Iolascon, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239967/
https://www.ncbi.nlm.nih.gov/pubmed/35614293
http://dx.doi.org/10.1007/s12325-022-02179-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239967/
https://www.ncbi.nlm.nih.gov/pubmed/35614293
http://dx.doi.org/10.1007/s12325-022-02179-1

Ejemplares similares